Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Mark Andrew Rothera$32.8M
Market Cap • 24/04/20241998
(há 26 anos)
2021
(3 years ago)
NASDAQ
Listagem
Cardiff
Sede • California32
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
VIRXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.